Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from BioLargo ( (BLGO) ).
On September 25, 2025, BioLargo announced the revocation of Pooph Inc.’s license to use its technology due to Pooph’s failure to meet contractual obligations, including $3.8 million in unpaid royalties and product invoices. This decision impacts Pooph’s ability to market and sell products based on BioLargo’s patents and proprietary information, significantly affecting Pooph’s operations. BioLargo remains committed to advancing its technology portfolio and protecting its intellectual property, despite the termination of the business relationship with Pooph.
Spark’s Take on BLGO Stock
According to Spark, TipRanks’ AI Analyst, BLGO is a Neutral.
BioLargo’s overall stock score is primarily influenced by its strong revenue growth potential, despite ongoing profitability and cash flow challenges. Technical indicators suggest mixed momentum, while valuation metrics highlight the company’s current unprofitability. The absence of earnings call data and corporate events did not impact the score.
To see Spark’s full report on BLGO stock, click here.
More about BioLargo
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company focuses on addressing PFAS contamination, advanced water and wastewater treatment, odor and VOC control, air quality improvement, energy-efficiency, safe on-site energy storage, and infection control. BioLargo develops novel technologies into product offerings and extends their commercial reach through licensing and partnerships.
Average Trading Volume: 387,728
Technical Sentiment Signal: Strong Sell
Current Market Cap: $58.43M
For a thorough assessment of BLGO stock, go to TipRanks’ Stock Analysis page.